Kiniksa Pharmaceuticals (KNSA) Technical (Analysis) Reports Kiniksa Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Kiniksa Pharmaceuticals (KNSA)
Technical Analysis Report for USA stock KNSA Kiniksa Pharmaceuticals. Dated: 03 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock KNSA Kiniksa Pharmaceuticals then click here. or read Experts views on Kiniksa Pharmaceuticals or Forecast & share price targets of Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals Opened at 47.41 and Closed at: 47.85, which is 1.94% of previous session's close. It moved within a range of 47.24 and 48.44
The session was a Bullish session with an average volume of 496300, which is -30.06% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 47.55 and resistance for tomorrow is 48.75
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 47.25, 46.64 resistance for tomorrow's hourly charts is 48.45, 49.04
10 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 50.83 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 54.05 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 50.53 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 47.4 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Kiniksa Pharmaceuticals is 43.06 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Kiniksa Pharmaceuticals is at 54.05 and 200 DMA is at 43.06, while 50 DMA and 100 DMA are at 50.53 and 47.4 respectively
Kiniksa Pharmaceuticals (KNSA) moving average of 20 SMA is at 54.05 and 20 EMA is at 51.72
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Wed Jun | 47.85 | 54.05 | 51.72 |
| 02 Tue Jun | 46.92 | 54.57 | 52.13 |
| 01 Mon Jun | 48.43 | 55.06 | 52.68 |
| 29 Fri May | 48.38 | 55.52 | 53.13 |
| 28 Thu May | 50.84 | 55.87 | 53.63 |
| 27 Wed May | 51.84 | 56.01 | 53.92 |
Kiniksa Pharmaceuticals (KNSA) moving average of 50 SMA is at 50.53 and 50 EMA is at 50.72
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Wed Jun | 47.85 | 50.53 | 50.72 |
| 02 Tue Jun | 46.92 | 50.47 | 50.84 |
| 01 Mon Jun | 48.43 | 50.45 | 51 |
| 29 Fri May | 48.38 | 50.4 | 51.1 |
| 28 Thu May | 50.84 | 50.35 | 51.21 |
| 27 Wed May | 51.84 | 50.27 | 51.23 |
Kiniksa Pharmaceuticals (KNSA) moving average of 100 SMA is at 47.4 and 100 EMA is at 47.97
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Wed Jun | 47.85 | 47.4 | 47.97 |
| 02 Tue Jun | 46.92 | 47.34 | 47.97 |
| 01 Mon Jun | 48.43 | 47.29 | 47.99 |
| 29 Fri May | 48.38 | 47.23 | 47.98 |
| 28 Thu May | 50.84 | 47.16 | 47.97 |
| 27 Wed May | 51.84 | 47.07 | 47.91 |
Kiniksa Pharmaceuticals (KNSA) moving average of 200 SMA is at 43.06 and 200 EMA is at 43.11
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Wed Jun | 47.85 | 43.06 | 43.11 |
| 02 Tue Jun | 46.92 | 42.99 | 43.06 |
| 01 Mon Jun | 48.43 | 42.93 | 43.02 |
| 29 Fri May | 48.38 | 42.85 | 42.97 |
| 28 Thu May | 50.84 | 42.78 | 42.92 |
| 27 Wed May | 51.84 | 42.69 | 42.84 |
Zimmer Biomet has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Zimmer Biomet, about 20.43% more returns!
U S has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in U S, about 1.84% more returns!
Stryker Corporation has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Stryker Corporation, about 18.74% more returns!
Iqvia Holdings has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Iqvia Holdings, about 20.99% more returns!
Edwards Lifesciences has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 21.21% more returns!
Xenon Pharmaceuticals has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 9.07% more returns!
Tg Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Tg Therapeutics, about 13.37% more returns!
Kiniksa Pharmaceuticals has performed better than Sutro Biopharma in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!
Kiniksa Pharmaceuticals has performed better than Phibro Animal in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!
Merit Medical has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Merit Medical, about 16.24% more returns!
Hutchison China has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Hutchison China, about 2.04% more returns!
Exelixis Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Exelixis Inc, about 23.78% more returns!
Ensign Group has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Ensign Group, about 12.57% more returns!
Dexcom Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Dexcom Inc, about 38.39% more returns!
Kiniksa Pharmaceuticals has performed better than Cytomx Therapeutics in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!
Caredx Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 24.32% more returns!
Biolife Solutions has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 43.12% more returns!
Axsome Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 22.71% more returns!
Kiniksa Pharmaceuticals has performed better than Assembly Biosciences in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!
Kiniksa Pharmaceuticals Technical analysis of indicators
Price action analysis of Kiniksa Pharmaceuticals (KNSA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Kiniksa Pharmaceuticals in short term and the sell signal is strong.
Kiniksa Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Kiniksa Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Kiniksa Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.63 and Kiniksa Pharmaceuticals KNSA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Kiniksa Pharmaceuticals KNSA stock. Volume based technical analysis of Kiniksa Pharmaceuticals KNSA stock is negative.
Kiniksa Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock KNSA Kiniksa Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And KNSA Experts View which covers a lot of information including buying and selling signals
KNSA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Kiniksa Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Kiniksa Pharmaceuticals (KNSA) Technical (Analysis) Reports Kiniksa Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


